Ross Wollen - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Ross Wollen's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Ross Wollen
Verified
Senior Writer, Diabetes Daily
Newcastle
Beats
Live News
Music, cooking, travel.
Content
By Ross Wollen| MSN (US) Verified Continue reading More for You Continue reading More for You
By Ross Wollen| Diabetes Daily@ There is only one treatment that can delay the development of type 1 diabetes. It’s a drug named teplizumab (Tzield). When given to people with early type 1, it delays the progression toward full-blown diabetes by an average of three years. Tzield was approved in late 2022, but many people in the type 1 diabetes community are still unaware of it. That’s understandable.
By Ross Wollen| MSN (US) Verified Continue reading More for You Continue reading More for You
Company Info
Diabetes Daily
Diabetes Daily is an online platform and community that supports individuals living with diabetes. Founded in 2005 by David Edelman and Elizabeth Zabell Edelman, it aims to empower users through education, community engagement, and practical guidance. Operating under the Everyday Health Group, Diabetes Daily serves nearly a million members through its website, forums, and social media channels. The platform offers a variety of resources, including educational content on diabetes management, lifestyle strategies, and the latest medical insights. Users can access detailed articles, guides, and recipes tailored to diabetes management. Community support is a key feature, allowing members to share experiences and connect with peers. Additionally, Diabetes Daily provides updates on advancements in diabetes technology and treatments, ensuring users stay informed about the latest developments in the field.
Founded: 2005